Blarcamesine works better when taken earlier in Alzheimer's: Study

Blarcamesine works better when taken earlier in Alzheimer's: Study

An experimental oral therapy called blarcamesine appears to slow the progression of Alzheimer’s disease, reducing the rate of cognitive decline and preserving daily function over the long term, according to new trial data from its developer, Anavex Life Sciences. The data “indicate disease-modifying effect of oral blarcamesine and highlight the importance of early and continued long-term treatment of chronic Alzheimer’s disease,” Marwan Sabbagh,…